<table width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>TABLE I: The Effect of Other Drugs on Lovastatin Exposure When Both Were Co-administered</caption>
<col align="left" valign="middle" width="18%"></col>
<col align="center" valign="middle" width="15%"></col>
<col align="center" valign="middle" width="20%"></col>
<col align="center" valign="middle" width="16%"></col>
<col align="center" valign="middle" width="13%"></col>
<col align="center" valign="middle" width="18%"></col>
<tbody>
<tr>
<td rowspan="2" stylecode="Lrule Rrule Botrule"></td>
<td rowspan="2" stylecode="Rrule Botrule">
<content stylecode="bold">Number of Subjects</content>
</td>
<td rowspan="2" stylecode="Rrule Botrule">
<content stylecode="bold">Dosing of Coadministered Drug or Grapefruit Juice</content>
</td>
<td rowspan="2" stylecode="Rrule Botrule">
<content stylecode="bold">Dosing of Lovastatin</content>
</td>
<td colspan="2" stylecode="Rrule Botrule">
<content stylecode="bold">AUC Ratio<footnote id="ft1.1">Results based on a chemical assay.</footnote>
<br/>(with / without coadministered drug)<br/>No Effect = 1.00</content>
</td>
</tr>
<tr>
<td align="center" stylecode="Rrule Botrule">
<content stylecode="bold">Lovastatin</content>
</td>
<td stylecode="Rrule Botrule">
<content stylecode="bold">Lovastatin acid</content>
<footnote>Lovastatin acid refers to the Î²-hydroxyacid of lovastatin.</footnote>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Gemfibrozil</td>
<td stylecode="Rrule">11</td>
<td stylecode="Rrule">600 mg BID for 3 days</td>
<td stylecode="Rrule">40 mg</td>
<td stylecode="Rrule">0.96</td>
<td stylecode="Rrule">2.80</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Itraconazole<footnote>The mean total AUC of lovastatin without itraconazole phase could not be determined accurately. Results could be representative of strong CYP3A4 inhibitors such as ketoconazole, posaconazole, clarithromycin, telithromycin, HIV protease inhibitors, and nefazodone.</footnote>
</td>
<td stylecode="Rrule">12</td>
<td stylecode="Rrule">200 mg QD for 4 days</td>
<td stylecode="Rrule">40 mg on Day 4</td>
<td stylecode="Rrule">&gt; 36<footnote id="ft1.2">Estimated minimum change. </footnote>
</td>
<td stylecode="Rrule">22</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule"></td>
<td stylecode="Rrule">10</td>
<td stylecode="Rrule">100 mg QD for 4 days</td>
<td stylecode="Rrule">40 mg on Day 4</td>
<td stylecode="Rrule">&gt; 14.8<footnoteref idref="ft1.2"></footnoteref>
</td>
<td stylecode="Rrule">15.4</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Grapefruit Juice<footnote id="ft1.3">The effect of amounts of grapefruit juice between those used in these two studies on lovastatin pharmacokinetics has not been studied.</footnote>
<br/>(high dose)</td>
<td stylecode="Rrule">10</td>
<td stylecode="Rrule">200 mL of double-strength TID<footnote>Double-strength: one can of frozen concentrate diluted with one can of water. Grapefruit juice was administered TID for 2 days, and 200 mL together with single dose lovastatin and 30 and 90 minutes following single dose lovastatin on Day 3.</footnote>
</td>
<td stylecode="Rrule">80 mg single dose</td>
<td stylecode="Rrule">15.3</td>
<td stylecode="Rrule">5.0</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Grapefruit Juice<footnoteref idref="ft1.3"></footnoteref>
<br/>(low dose)</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">8 oz (about 250 mL) of single-strength<footnote>Single-strength: one can of frozen concentrate diluted with 3 cans of water. Grapefruit juice was administered with breakfast for 3 days, and lovastatin was administered in the evening on Day 3.</footnote> for 4 days </td>
<td stylecode="Rrule">40 mg single dose</td>
<td stylecode="Rrule">1.94</td>
<td stylecode="Rrule">1.57</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Cyclosporine</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">Not described<footnote>Cyclosporine-treated patients with psoriasis or post kidney or heart transplant patients with stable graft function, transplanted at least 9 months prior to study.</footnote>
</td>
<td stylecode="Rrule">10 mg QD for 10 days</td>
<td stylecode="Rrule">5- to 8-fold</td>
<td stylecode="Rrule">ND<footnote>ND = Analyte not determined.</footnote>
</td>
</tr>
<tr>
<td rowspan="2" stylecode="Lrule Rrule Botrule"></td>
<td rowspan="2" stylecode="Rrule Botrule">
<content stylecode="bold">Number of Subjects</content>
</td>
<td rowspan="2" stylecode="Rrule Botrule">
<content stylecode="bold">Dosing of Coadministered Drug or Grapefruit Juice</content>
</td>
<td rowspan="2" stylecode="Rrule Botrule">
<content stylecode="bold">Dosing of Lovastatin</content>
</td>
<td colspan="2" stylecode="Rrule Botrule">
<content stylecode="bold">AUC Ratio<footnoteref idref="ft1.1"></footnoteref>
<br/>(with / without coadministered drug)<br/>No Effect = 1.00</content>
</td>
</tr>
<tr stylecode="Botrule">
<td align="center" colspan="2" stylecode="Rrule Botrule">
<content stylecode="bold">Total Lovastatin acid<footnote id="ft1.4">Lactone converted to acid by hydrolysis prior to analysis. Figure represents total unmetabolized acid and lactone.</footnote>
</content>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Diltiazem</td>
<td stylecode="Rrule">10</td>
<td stylecode="Rrule">120 mg BID for 14 days</td>
<td stylecode="Rrule">20 mg</td>
<td colspan="2" stylecode="Rrule">3.57<footnoteref idref="ft1.4"></footnoteref>
</td>
</tr>
</tbody>
</table>